Randomized controlled trial2018Open access

Walnut Consumption Alters the Gastrointestinal Microbiota, Microbially Derived Secondary Bile Acids, and Health Markers in Healthy Adults: A Randomized Controlled Trial

Holscher HD, Guetterman HM, Swanson KS, An R, Matthan NR, Lichtenstein AH, Novotny JA, Baer DJ

The Journal of nutrition · 138 citations

Review labels

Controlled feedingFunding not disclosed

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Food provided by researchers

Who paid for it

Funding
Funding not disclosed

Publication

Published
2018-01-26 · J Nutr · vol. 148 · issue 6 · pp. 861–867
Publisher
Elsevier BV
Cited
185 citations · more than 99% of similar papers · 12.2× the field average
Impact
Top 10% most cited in its field
References
56 works
Access
Open access (hybrid journal) · CC-BY-NC
Research areas
Nuts composition and effects · Peanut Plant Research Studies · Botany, Ecology, and Taxonomy Studies
Keywords
Deoxycholic acid, Bile acid, Feces, Gut flora, Randomized controlled trial, Medicine, Lithocholic acid, Physiology, Bifidobacterium, Roseburia, Crossover study, Food science, Biology, Internal medicine, Gastroenterology, Lactobacillus, Immunology, Microbiology, Fermentation
MeSH
humans, bacteria, juglans, bile acids and salts, diet, cross-over studies, adult, aged, middle aged, female, male, biomarkers, gastrointestinal microbiome

8 authors

From US

  • Hannah D. Holscher · correspondingUniversity of Illinois Urbana-Champaign
  • Heather M. GuettermanUniversity of Illinois Urbana-Champaign
  • Kelly Scott SwansonUniversity of Illinois Urbana-Champaign
  • Ruopeng AnUniversity of Illinois Urbana-Champaign
  • Nirupa Rachel MatthanTufts University; Jean Mayer Human Nutrition Research Center on Aging
  • Alice Hinda LichtensteinTufts University; Jean Mayer Human Nutrition Research Center on Aging

Abstract

Background

Epidemiologic data suggest that diets rich in nuts have beneficial health effects, including reducing total and cause-specific mortality from cancer and heart disease. Although there is accumulating preclinical evidence that walnuts beneficially affect the gastrointestinal microbiota and gut and metabolic health, these relations have not been investigated in humans.

Objective

We aimed to assess the impact of walnut consumption on the human gastrointestinal microbiota and metabolic markers of health.

Methods

A controlled-feeding, randomized crossover study was undertaken in healthy men and women [n = 18; mean age = 53.1 y; body mass index (kg/m2): 28.8]. Study participants received isocaloric diets containing 0 or 42 g walnuts/d for two 3-wk periods, with a 1-wk washout between diet periods. Fecal and blood samples were collected at baseline and at the end of each period to assess secondary outcomes of the study, including effects of walnut consumption on fecal microbiota and bile acids and metabolic markers of health.

Results

Compared with after the control period, walnut consumption resulted in a 49-160% higher relative abundance of Faecalibacterium, Clostridium, Dialister, and Roseburia and 16-38% lower relative abundances of Ruminococcus, Dorea, Oscillospira, and Bifidobacterium (P < 0.05). Fecal secondary bile acids, deoxycholic acid and lithocholic acid, were 25% and 45% lower, respectively, after the walnut treatment compared with the control treatment (P < 0.05). Serum LDL cholesterol and the noncholesterol sterol campesterol concentrations were 7% and 6% lower, respectively, after walnut consumption compared with after the control treatment (P < 0.01).

Conclusion

Walnut consumption affected the composition and function of the human gastrointestinal microbiota, increasing the relative abundances of Firmicutes species in butyrate-producing Clostridium clusters XIVa and IV, including Faecalibacterium and Roseburia, and reducing microbially derived, proinflammatory secondary bile acids and LDL cholesterol. These results suggest that the gastrointestinal microbiota may contribute to the underlying mechanisms of the beneficial health effects of walnut consumption. This trial was registered at www.clinicaltrials.gov as NCT01832909.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.